SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-039348
Filing Date
2023-08-08
Accepted
2023-08-08 07:05:32
Documents
13
Period of Report
2023-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K coya-20230808.htm   iXBRL 8-K 56625
2 EX-99.1 coya-ex99_1.htm EX-99.1 211695
  Complete submission text file 0000950170-23-039348.txt   403812

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT coya-20230808_pre.xml EX-101.PRE 10303
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT coya-20230808.xsd EX-101.SCH 2493
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT coya-20230808_lab.xml EX-101.LAB 14018
7 EXTRACTED XBRL INSTANCE DOCUMENT coya-20230808_htm.xml XML 4929
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41583 | Film No.: 231149260
SIC: 2834 Pharmaceutical Preparations